ARCHIVES

As Bristol’s Final Defenses Fall, IVAX Prepares Launch Of Generic Paclitaxel.

This article is from The Cancer Letter archive.

Vol. 26 No. 38 | October 20, 2000

Download PDF Visit The Full Archive

Related Articles

AHCPR Invites Ideas for Outcomes Research

June 7, 1996

Colorectal, Lung Cancer Screening Techniques Show No Mortality Improvement, Conferences Find

December 1, 1978

DePinho Explains Tenure Decision,Professors Dispute Key Details

May 30, 2014

President Signs Supplemental Funding For NIH And FDA.

July 11, 2008

Children’s Oncology Group to Select New Chairman; Four Leaders to Step Aside

April 28, 2000

In Brief: $100 Million Being Spent On Interferon In U.S., Rauscher Says; DeVita; Criticism Deserved

April 4, 1980